Tortoise Investment Management’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
VCM
VPM
VFT
Tortoise Investment Management's NUVB Position: Q2 2026 in Review
Tortoise Investment Management held its Nuvation Bio (NUVB) position steady in Q2 2026 at 13,752 shares worth $78.1K. The position accounts for 0.01% of the portfolio, ranked #252.
Tortoise Investment Management first reported a position in NUVB in Q1 2022 and has held it in 18 quarters since. The position peaked at $123K in Q4 2025. 156 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.
- Tortoise Investment Management held 13,752 shares of Nuvation Bio worth $78.1K as of Q2 2026.
- Tortoise Investment Management left its Nuvation Bio share count unchanged in Q2 2026.
- Nuvation Bio made up 0.01% of Tortoise Investment Management's portfolio in Q2 2026, its #252 holding.
- Tortoise Investment Management first reported a position in Nuvation Bio in Q1 2022 and has held it in 18 quarters since.
- Tortoise Investment Management's Nuvation Bio position peaked at $123K in Q4 2025.
- 156 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.
Based on Tortoise Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.